DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

E-ISSN： 1527-3350|61|6|1945-1956

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.6, 2015-06, pp. : 1945-1956

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepcidin and DNA promoter methylation in hepatocellular carcinoma

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognosis for Pedunculated Hepatocellular Carcinoma

Oncology, Vol. 57, Iss. 1, 1999-07 ,pp. : 23-28

Karger

Access to resources Recommend Favorite

DNA methylation‐based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1611-1619

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating markers for prognosis of hepatocellular carcinoma

By Wong Kwong-Fai

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 4, 2013-07 ,pp. : 319-329

Informa Healthcare

Access to resources Recommend Favorite

Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression

By Fang Song

Clinical and Experimental Medicine, Vol. 13, Iss. 2, 2013-05 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite